tiprankstipranks
Trending News
More News >
TELA Bio (TELA)
NASDAQ:TELA
US Market

TELA Bio (TELA) Earnings Dates, Call Summary & Reports

Compare
147 Followers

Earnings Data

Report Date
Aug 06, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.18
Last Year’s EPS
-0.51
Same Quarter Last Year
Based on 4 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 08, 2025
|
% Change Since: 11.11%
|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
TELA Bio's earnings call highlighted strong revenue growth and product demand, particularly in the European market, despite facing some challenges such as tariff impacts and increased net loss. The company's strategic organizational changes and innovative product launches position it well for future growth.
Company Guidance
During the TELA Bio First Quarter 2025 Earnings Conference Call, the company reported $18.5 million in revenue, marking a 12% year-over-year increase and 5% sequential growth compared to the fourth quarter of 2024. The revenue growth was driven by the strong performance of OviTex and OviTex PRS reinforced tissue matrix products, each showing approximately 152% revenue growth. TELA Bio also experienced a 17% growth in its European business over the same period last year. The company reaffirmed its 2025 revenue guidance of $85 to $88 million, projecting a 23% to 27% growth over the full year 2024. The call highlighted the effectiveness of the new territory manager (TM) and account specialist (AS) structure, with 70 TMs and 22 ASs in place, and the successful training of 25 new sales team members. The gross margin for the first quarter was 67.6%, slightly down from 68.3% the previous year, impacted by excess and obsolete inventory adjustments. Operating and net losses were $10.5 million and $11.3 million, respectively, with expectations for both to decrease over the course of the year. TELA Bio also addressed the impact of a 10% tariff on products shipped from New Zealand, expected to reduce the gross margin by 50 to 100 basis points.
Revenue Growth
TELA Bio reported $18.5 million in revenue for Q1 2025, marking a 12% year-over-year increase and a 5% sequential growth from Q4 2024.
Strong Product Demand
OviTex and OviTex PRS products saw significant demand, with each growing approximately 152% year-over-year.
European Market Expansion
TELA Bio's European business grew by 17% compared to Q1 2024, indicating a strong international presence.
Sales Force Effectiveness
The new territory manager and account specialist structure has been effective, with 25 new sales team members trained in 2025.
Market Leadership in Hernia Repair
TELA Bio is well positioned to capitalize on the industry's shift away from synthetic mesh, with OviTex products demonstrating strong market traction.
Innovative Product Launches
Launched larger sizes of OviTex PRS to address more complex procedures, enhancing operating room efficiency and reducing costs.
Wide Engagement with Surgeons
Presented products to over 5,000 surgeons globally through various educational and symposium events.
---

TELA Bio (TELA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TELA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 06, 2025
2025 (Q2)
-0.18 / -
-0.51
May 08, 2025
2025 (Q1)
-0.20 / -0.25
-0.23-8.70% (-0.02)
Mar 20, 2025
2024 (Q4)
-0.21 / -0.23
-0.5356.60% (+0.30)
Nov 07, 2024
2024 (Q3)
-0.41 / -0.42
-0.456.67% (+0.03)
Aug 12, 2024
2024 (Q2)
-0.46 / -0.51
-0.46-10.87% (-0.05)
May 09, 2024
2024 (Q1)
-0.49 / -0.23
-0.6363.49% (+0.40)
Mar 21, 2024
2023 (Q4)
-0.45 / -0.53
-0.52-1.92% (-0.01)
Nov 09, 2023
2023 (Q3)
-0.48 / -0.45
-0.6429.69% (+0.19)
Aug 09, 2023
2023 (Q2)
-0.52 / -0.46
-0.8847.73% (+0.42)
May 11, 2023
2023 (Q1)
-0.55 / -0.63
-0.7516.00% (+0.12)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TELA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 08, 2025
$0.99$1.08+9.09%
Mar 20, 2025
$2.34$1.47-37.18%
Nov 07, 2024
$2.99$3.08+3.01%
Aug 12, 2024
$4.01$3.09-22.94%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does TELA Bio (TELA) report earnings?
TELA Bio (TELA) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
    What is TELA Bio (TELA) earnings time?
    TELA Bio (TELA) earnings time is at Aug 06, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TELA EPS forecast?
          TELA EPS forecast for the fiscal quarter 2025 (Q2) is -0.18.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis